Friday, September 12, 2014
Study finds PHF-W formula could cost-effectively reduce atopic dermatitis
Atopic dermatitis (AD) is one of the most common inflammatory chronically recurring skin disorders to affect infants and young children.
Given its chronic nature, AD puts a significant economic burden on the families of affected children, healthcare systems and society as a whole.
A recent study conducted in the Philippines sought to determine the cost-effectiveness of preventing this condition in Filipino infants, who are not exclusively breastfed, by feeding them with a 100% whey-based partially hydrolyzed formula (PHF-W) rather than a standard cows milk formula.
A Markov model was used in the study to estimate the risk of AD and the expected number of days with AD symptoms over six years for healthy, at-risk, Filipino infants not exclusively breastfed. The infants were then fed with either a PHF-W or standard cows milk formula for 17 weeks.
The results showed that the PHF-W was indeed a cost-effective (and cost saving) option relative to the standard formula and resulted in a 14% decrease in the incidence of AD among Filipino infants – representing a reduction of 22 days with AD symptoms.
The higher cost of the PHF-W was offset by decreased AD-related costs. The total cost savings were US$237 per child over the 6-year timeframe.
These results provide insights into the benefits of long-term prevention of AD in children.